Intellia Therapeutics Inc buy Raymond James
Start price
10.11.23
/
50%
€22.91
Target price
10.11.24
€53.33
Performance (%)
-31.17%
End price
11.11.24
€15.77
Summary
This prediction ended on 11.11.24 with a price of €15.77. Massive losses of -31.17% were the result for the BUY prediction by Raymond_James. Raymond_James has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intellia Therapeutics Inc | 1.230% | 1.230% | 76.471% |
| iShares Core DAX® | 2.554% | 0.562% | 14.142% |
| iShares Nasdaq 100 | 2.742% | -0.599% | 30.370% |
| iShares Nikkei 225® | 6.584% | 4.336% | 49.372% |
| iShares S&P 500 | 1.930% | -0.507% | 24.257% |
Comments by Raymond_James for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its price target lowered by analysts at Raymond James from $78.00 to $57.00. They now have an "outperform" rating on the stock.
Ratings data for NTLA provided by MarketBeat
In the thread Trading Intellia Therapeutics Inc
Die von Raymond_James gewählte maximale Laufzeit wurde überschritten